Werewolf Therapeutics (HOWL) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.43
-0.4
-0.36
-0.33

Details

Expected EPS
-0.405
Actual EPS
-0.38
Surprise EPS
0.03
Surprise Percent
+6.17%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.38 per share for Q4 2024.

0 Comments

Share your thoughts